Stock listing

Hansa Biopharma Ab

Selected listing: HNSBF · OTC · USD · US

Hansa Biopharma Ab (OTC:HNSBF), Health Technology. Latest release Sep 24, 2026: Hansa Biopharma Announces New Board Appointments.

HNSBF:OTCUSDUSUpdated October 3, 2026

Ticker: OTC:HNSBF
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: OTC
Currency: USD

About Hansa Biopharma Ab

The company focuses on developing innovative therapies for patients with rare immunological conditions. Hansa Biopharma aims to address unmet medical needs through its cutting-edge research and development efforts.

Latest news from Hansa Biopharma Ab

Hansa Biopharma Announces New Board Appointments

September 24, 2026

Bulletin from the Extraordinary General Meeting in Hansa Biopharma AB (publ)

September 22, 2026

Hansa Biopharma Announces Confidential Submission of Draft Registration Statement to the SEC to allow for a potential Listing of ADSs in the United States

August 21, 2026

Hansa Biopharma Reports Second Quarter and First Half Year 2026 Financial Results

July 22, 2026

Hansa Biopharma announces closing of €115 million licensing transaction with SERB Pharmaceuticals for Idefirix in Europe and MENA

July 1, 2026

All Hansa Biopharma Ab news →

Events

Replays

Hansa Biopharma AB (publ) (HNSA) Q2 2026 Earnings Call
Wed, Jul 22, 2026 · 08:00 AM ET
Watch
Hansa Biopharma AB (publ) (HNSA) Q1 2026 Earnings Call
Thu, Apr 23, 2026 · 08:00 AM ET
Watch
Hansa Biopharma AB (publ) (HNSA) Q4 2025 Earnings Call
Wed, Feb 11, 2026 · 08:00 AM ET
Watch

Research Hansa Biopharma Ab

Hansa Biopharma Ab company profile

View the public company page for Hansa Biopharma Ab on 6ix.

Hansa Biopharma Ab news

Read company news and market updates connected to Hansa Biopharma Ab.

Hansa Biopharma Ab investor events

Find investor webinars, events, and replay context for Hansa Biopharma Ab.